Mechanistically, the protective effects of AA were mediated by the activation of AMPKα that participates in the pathogenesis of cardiac hypertrophy and inhibition of the mammalian target of rapamycin (mTOR) pathway and ERK. The gene discussed is MTOR; the disease is cardiac hypertrophy.